Factual end-of-day data for GLENMARK: price and volume, delivery percentage, 52-week position, indicator levels and intraday order flow. Refreshed after every NSE session.
Traded volume of 4,79,931 shares was close to the 20-day average.
GLENMARK's delivery share of 37.5% was below its 20-day average of 43.0%.
Intraday order-flow data from VolumeLens tick classification — the running difference between aggressive buying and selling volume. This dataset is not published by any other Indian platform.
Large-trade volume split: 1,804 shares on the buy side vs 4,500 on the sell side.
Largest single buy-side trade: 902 shares at ₹2,414.50.
| Indicator | Reading (26 Aug 2026) |
|---|---|
| RSI (14) | 68.0 |
| 50-day EMA | ₹2,271.70 — close is above |
| 200-day EMA | ₹2,180.30 — close is above |
| SuperTrend (10, 3) | ₹2,243.85 — close is above the line |
Indicator values are computed from adjusted daily closes and describe where price sits relative to each level — they are statistics, not signals.
GLENMARK is a large-cap NSE stock in the Pharma sector (Drug Manufacturers - Specialty & Generic industry), with a market capitalisation of about ₹55,735 crore.
Footprint chart, DOM ladder, cumulative delta and volume profile — free to explore.
On 26 Aug 2026, 37.5% of GLENMARK's traded volume was marked for delivery (1,79,829 shares delivered). The 20-day average delivery is 43.0%.
GLENMARK closed at ₹2,438.30 on 26 Aug 2026 (+1.60% vs the previous close).
52-week high ₹2,474.00, 52-week low ₹1,792.60. The latest close is -1.44% from the 52-week high.